Close menu




July 22nd, 2026 | 08:10 CEST

100% Upside Potential and More: What Analysts Predict for Desert Gold Ventures, Oracle, and Hypoport

  • Mining
  • Gold
  • geopolitics
  • Financial
  • cloud
Photo credits: Pixabay

Securities analysts are usually deliberately cautious so as not to raise false expectations. With Oracle and Hypoport, however, they are coming out of the woodwork with price targets that promise the potential for a doubling of the share price—and for the Canadian mining stock Desert Gold Ventures, even significantly more. What is behind these estimates, how realistic are they, and what facts should investors keep in mind?

time to read: 6 minutes | Author: Jens Castner
ISIN: DESERT GOLD VENTURES | CA25039N4084 | TSXV: DAU , OTCQB: DAUGF , ORACLE CORP. DL-_01 | US68389X1054 , HYPOPORT SE NA O.N. | DE0005493365

Table of contents:


    Author

    Jens Castner

    Jens Castner

    The Nuremberg native brings over three decades of capital markets experience, backed by a career shaped by deep market insight and a genuine passion for investing. His journey began in 1994 through an investment club among colleagues – a formative experience that sparked a lifelong dedication to identifying compelling investment opportunities.

    Following senior editorial roles at Nürnberger Nachrichten, €uro am Sonntag, and €uro, he went on to serve as Editor-in-Chief of the renowned investor magazine Börse Online from 2014, where he played a key role in shaping high-quality financial journalism for a broad investor audience.

    About the author



    Tag cloud


    Shares cloud

    Desert Gold: From Explorer to Producer

    Bold price targets have become rare amid strict regulatory requirements. Yet now and then, experts go public with estimates that cause a stir. Three current examples show just how wide the gap between the current share price and the experts' target can be. The most striking case is that of Desert Gold Ventures. Analysts at GBC Research estimate the intrinsic value of the stock at CAD 0.93 or EUR 0.59. Compared to the current share price of around CAD 0.11 (EUR 0.07 on German exchanges), this would represent a significant increase. Among other things, the Canadian company is developing a gold project in the Senegal Mali Shear Zone (SMSZ), a 440 km² license area that borders mines operated by giants such as Barrick Mining and B2Gold. To date, the project has identified a resource of approximately 1.2 million ounces of gold, most of which is near-surface and thus relatively inexpensive to mine.

    Instead of undertaking a capital-intensive large-scale project, the management team led by CEO Jared Scharf is taking a cost-efficient approach. At the Barani East site in Mali, a mobile gravity processing plant will initially crush 200 to 240 metric tons of ore per day. The objective is to produce the first gold, and thus the first cash flow, before gradually expanding production capacity. GBC Research derives its valuation of the company from several key components: the processing plant (USD 89.6 million), the Barani East project itself (USD 124.0 million, based on the economic study), the Tiegba exploration property in Côte d'Ivoire (USD 9.5 million), and additional mineral resources (USD 21.7 million). Combined, these assets result in an intrinsic value of USD 244.8 million, or CAD 344.3 million—equivalent to a fair value of CAD 0.93 per share.

    The time for a potential re-rating may have arrived. Just a few days ago, on July 19, the processing plant arrived at Barani East—a pivotal moment when a mining explorer begins its transition from explorer to producer, turning potential into an operating business. According to CEO Scharf, everything is proceeding according to plan: "With the gravity plant now on site, we are closer than ever to achieving first gold production. I look forward to providing the market with further guidance as soon as key milestones are reached." Consequently, price-sensitive announcements regarding the plant's progress can be expected in the coming days. The opportunity lies in what is known as a "re-rating". If production begins as planned, the market might no longer classify Desert Gold as a capital-hungry explorer, but rather as a cash-flow-generating gold producer.

    Oracle: AI Boom Meets Shaky Balance Sheet

    Even though the GBC calculation is supported by plausible figures, a target more than 700% above the current price seems very high at first glance. Most investors would certainly be satisfied with a 100% gain. Yet even the boldness to set price targets at double the current price is rather rare among analysts. However, there are exceptions, even among established corporations. For Oracle, for example, the US investment bank Jefferies puts the fair value at USD 320 per share, which, compared to the current share price of around USD 125, represents upside potential of more than 150%. While this is the highest among the price targets set by the major firms, Jefferies is not alone in this assessment. Deutsche Bank considers USD 300 achievable, while UBS sees USD 285—both more than 100% above the current level.

    Oracle has traditionally generated revenue from database software and enterprise applications, but has recently transformed itself into a sought-after infrastructure partner for the AI industry. Through its cloud division OCI (Oracle Cloud Infrastructure), the company operates data centers for clients such as OpenAI and Meta Platforms and has a backlog of orders worth several hundred billion US dollars. It was precisely this boom that ultimately proved to be the stock's undoing. Since its 2025 high of around USD 325, triggered by the announcement of a multi-billion-dollar cloud deal with OpenAI, the stock has fallen significantly. Investors are concerned about the financing of the massive AI investments: Oracle has taken on more than USD 130 billion in debt to build data centers, while free cash flow has recently been significantly negative. In early July, the rating agency S&P downgraded the company's credit rating to BBB-, just one notch above junk status. The order book is therefore robust, but the balance sheet is strained—this contradiction has fueled the debate surrounding the stock ever since.

    Hypoport: A Comeback After the Price Drop?

    In Germany, too, there are occasional examples of price targets that suggest dream-like returns for investors. One of them is Hypoport. In May, the private bank Berenberg set a price target of EUR 190, representing nearly 100% upside from the current share price. Through Europace, Hypoport operates Germany's largest B2B platform for real estate financing: banks, insurers, and financing brokers use it to process mortgage loans, home savings contracts, and installment loans; the company earns revenue from platform fees and volume-based commissions.

    From its high of over EUR 600 in 2021, the stock has since fallen to EUR 88. The reason is a combination of a more challenging overall real estate financing market and recent disappointing figures. In the first half of the year, the financing volume brokered via Europace stagnated at EUR 38.3 billion, while in the high-margin home savings segment, volume actually plummeted by 16%. According to CEO Ronald Slabke, this is no cause for alarm. "In the first quarter of 2026, we saw temporarily higher closing rates as a result of the spike in interest rates triggered by the Iran conflict, which led to the expected slowdown in the overall market in the second quarter," the executive explains. He added: "Looking at the half-year as a whole, we are on par with the strong first half of 2025 and have gained further market share." The stock nevertheless reacted to the figures with a noticeable decline, underscoring how sensitive the market is to any sign of a slowdown.

    Will Berenberg be proven right with its bold price target? It is not entirely out of the question, as a look at the long-term chart shows. After the initial crash from EUR 600 to below EUR 100 in 2022, the share price initially recovered toward EUR 200 before plummeting again in the fall of 2023. This was followed by a rally to over EUR 300 by mid-2024. For Oracle, too, the rise into the league of the world's most significant software companies, much like that of its longtime rival SAP, was not always a straight path.

    Conclusion: Between Daydreaming and Track Record

    When analysts make bold predictions, only time will tell whether the expectations they have raised will materialize. The fact is that a doubling of the share price is significantly more likely for smaller companies like Desert Gold—if only because the share price, currently at CAD 0.11 or EUR 0.07, is so low, and the market capitalization, at just under CAD 38 million, is so small. For Oracle, the market capitalization would have to rise by more than USD 300 billion for the price to double; for Hypoport, by more than half a billion EUR. On the other hand, the risk is naturally lower for established companies. Both Oracle and Hypoport have diversified business models with recurring revenue and a long-standing track record, while Desert Gold depends on the technically challenging start of production in Mali. However, if successful, the leverage for the gold mining stock is far greater. The 1.2 million ounces in the ground currently have a market value of more than USD 4.8 billion, which, even after deducting production costs of USD 1.4 billion, is more than 100 times the current market capitalization—and this calculation does not yet take the other projects into account. This shows that GBC Research's price target could be more than just a pipe dream.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Jens Castner

    Jens Castner

    The Nuremberg native brings over three decades of capital markets experience, backed by a career shaped by deep market insight and a genuine passion for investing. His journey began in 1994 through an investment club among colleagues – a formative experience that sparked a lifelong dedication to identifying compelling investment opportunities.

    Following senior editorial roles at Nürnberger Nachrichten, €uro am Sonntag, and €uro, he went on to serve as Editor-in-Chief of the renowned investor magazine Börse Online from 2014, where he played a key role in shaping high-quality financial journalism for a broad investor audience.

    About the author



    Related comments:

    Commented by Jens Castner on October 30th, 2026 | 05:45 CET

    When the stock market gets it wrong: Schott Pharma clears its name; Lahontan Gold and Instone are the next candidates

    • Speciality glass
    • Gold
    • Real estate
    • Chemicals
    • Silver
    • Expropriation
    • Health
    • Berlin
    • Misvaluations
    • Mining
    • Schott Pharma
    • Instone Real Estate
    • Lahontan Gold

    Markets are quick to judge, and often paint companies with a broad brush. When one company runs into difficulties, its competitors immediately come under suspicion too. Schott Pharma has already been through this and dispelled the doubts with strong figures. Its share price is recovering. For Lahontan Gold and Instone Real Estate, the recovery has yet to come. The Canadian gold explorer is being punished alongside the major producers, while the property developer is being grouped with Berlin's residential landlords. In both cases, the facts tell a different story. The share price upside is considerable.

    Read

    Commented by Jens Castner on October 29th, 2026 | 05:40 CET

    A Breakout in the Making? Desert Gold Ventures and Oklo following in Moderna's footsteps

    • Cancer therapy
    • Gold
    • Nuclear power
    • Biotech
    • Commodities
    • Data centres
    • Desert Gold
    • Moderna
    • Oklo
    • Analysts
    • Price targets
    • Milestones
    • Quarterly reports
    • Precious metal

    Created and published on behalf of Desert Gold Ventures.

    Moderna has already made the big leap. Yet the best trial data in the company's history sent the shares tumbling, because the success was already priced in. The situation is different for two stocks that have also reached crucial milestones but still attract little attention on the stock market. Desert Gold Ventures is on the verge of its first gold production in Mali. Nuclear power specialist Oklo has commissioned its first reactor, but still needs a little more time before its commercial breakthrough. Analysts' price targets for both shares are several times their current prices.

    Read

    Commented by Carsten Mainitz on October 29th, 2026 | 05:31 CET

    Gold, Tickets, Turnarounds! Why Stock Pickers Should Take a Closer Look at DRC Gold, CTS Eventim and Mutares Now

    • Stock Picking
    • Alpha
    • Investments
    • Gold
    • Exploration
    • Acquisition
    • Activist Investor

    The stock market is no petting zoo. Investors seeking returns have to go hunting themselves. Stock picking is the art of finding tomorrow's winners before the rest of the market wakes up. Under the leadership of industry veteran Klaus Eckhof, DRC Gold is working to take a stake in a gold project in the northeast of the Democratic Republic of the Congo. This could take the company to a whole new level. CTS Eventim is attracting renewed attention thanks to an activist investor. This could boost the share price. Mutares has many irons in the fire. Who is ahead?

    Read